文献速递炎症性肠病

韩国炎症性肠病患者带状疱疹感染风险增加

Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-05-29

韩国全国人群研究显示炎症性肠病患者带状疱疹发病率18.34/1000人年,标准化发病比1.48(95%CI 1.42-1.54);克罗恩病高于溃疡性结肠炎,男性高于女性;医院巢式病例对照研究显示糖皮质激素使用与感染相关。

要点

  • 炎症性肠病患者带状疱疹标准化发病比为1.48(95%CI 1.42-1.54)。
  • 克罗恩病标准化发病比1.90高于溃疡性结肠炎的1.36(P<.001)。
  • 男性标准化发病比1.63高于女性的1.33(P<.001)。

核心结论

  • 韩国炎症性肠病患者带状疱疹感染风险增加,尤其在男性、较年轻及克罗恩病患者中。
  • 糖皮质激素使用增加炎症性肠病患者带状疱疹感染风险。

研究设计与样本

  • 全国性人群为基础的研究及医院为基础巢式病例对照研究。
  • 利用2009-2013年韩国国民健康保险索赔数据库计算发病率及标准化发病比。
  • 巢式病例对照研究中,300例合并带状疱疹感染的炎症性肠病患者与895例无带状疱疹的炎症性肠病患者匹配。

主要发现

  • 全国人群研究中,炎症性肠病患者带状疱疹发病率为18.34/1000人年,标准化发病比为1.48(95%CI 1.42-1.54)。
  • 克罗恩病患者标准化发病比1.90高于溃疡性结肠炎患者的1.36(P<.001)。
  • 男性患者标准化发病比1.63高于女性患者的1.33(P<.001)。
  • 带状疱疹发病率随年龄增加而升高(P趋势<.001),而标准化发病比随年龄增加而降低(P趋势<.001)。
  • 巢式病例对照研究中,糖皮质激素使用与带状疱疹感染相关:溃疡性结肠炎调整OR 2.44(95%CI 1.18-5.05),克罗恩病调整OR 2.70(95%CI 1.25-5.83)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Few data are available on risk of herpes zoster (HZ) infection in Asian patients with inflammatory bowel diseases (IBD). We investigated whether patients with IBD in Korea have an increased risk of HZ and sought to identify risk factors for infection. METHODS: We performed a nationwide population-based study and a hospital-based, nested case-control study. Using the 2009-2013 data from the Korean national health insurance claims database, we calculated incidence rates and standardized incidence ratios (SIRs) of HZ infection in patients with IBD compared with the entire Korean population. In the nested case-control study, within a hospital-based cohort, 300 patients with IBD and HZ infection were matched with 895 patients with IBD without HZ. RESULTS: In the nationwide population-based study, the incidence rate and SIR of HZ infection in patients with IBD were 18.34/1000 person-years and 1.48 (95% CI, 1.42-1.54), respectively. The SIR for HZ infection was higher in patients with Crohn's disease than in patients with ulcerative colitis (1.90 vs 1.36; P < .001) and higher in male patients than female patients (1.63 vs 1.33; P < .001). The incidence rate of HZ increased with age (P trend < .001), whereas the SIR of HZ infection decreased with age (P trend < .001). In the nested case-control study, corticosteroid use was associated with HZ infection (for ulcerative colitis, adjusted odds ratio, 2.44; 95% CI, 1.18-5.05 and for Crohn's disease, adjusted odds ratio, 2.70; 95% CI 1.25-5.83). CONCLUSIONS: In a population-based study in Korea, we found patients with IBD to have an increased risk for HZ infection-especially among patients who are male, younger, or have Crohn's disease. Corticosteroid use increases risk of HZ infection in patients with IBD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Chang K, Lee HS, Kim YJ, et al. Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea. Clin Gastroenterol Hepatol. 2018. PMID: 29857150. doi:10.1016/j.cgh.2018.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。